{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:16:02Z","timestamp":1790842562846,"version":"4.1.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Central nervous system disorders significantly affect the lives and health of millions of people worldwide. Despite many therapeutic drugs are available that could potentially target central nervous system disorders, their clinical utility is severely constrained by their inability to cross the blood-brain barrier (BBB). Fortunately, nanotechnology has been advanced to offers a solution to allow drugs reaching the targeted brain regions safely, efficiently, and precisely through nasal drug delivery system (NDDS), bypassing the BBB completely. This strategy can promote the drug accumulated in the targeted brain region, improve drug bioavailability, and minimal side effects and mucociliary clearance effectively. In this review, we elaborate recent advances in the use of lipid-based nanoparticles, involving liposomes, nanoemulsions, nanostructured lipid carriers, and solid lipid nanoparticles. Besides, we particularly introduced the nasal cavity physiological structure, and further summarized the nose-to-brain drug delivery pathways, including olfactory, trigeminal, and blood circulation pathway. Moreover, the mechanism and route of NDDS by various types of nanoparticles are also highlighted.<\/jats:p>","DOI":"10.3389\/fcell.2023.1214450","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T05:29:38Z","timestamp":1692682178000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":66,"title":["Lipid-based nanoparticles via nose-to-brain delivery: a mini review"],"prefix":"10.3389","volume":"11","author":[{"given":"Yang","family":"Xinchen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Jiaoqiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","article-title":"Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting","volume":"321","author":"Agrawal","year":"2020","journal-title":"J. Control. Release"},{"key":"B2","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.1021\/acsomega.0c01592","article-title":"Nanocarriers as potential drug delivery candidates for overcoming the blood-brain barrier: challenges and possibilities","volume":"5","author":"Ahlawat","year":"2020","journal-title":"Acs Omega"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1039\/c6nr07581a","article-title":"Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles","volume":"9","author":"Ahmad","year":"2017","journal-title":"Nanoscale"},{"key":"B4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijpharm.2014.05.004","article-title":"Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug","volume":"470","author":"Alam","year":"2014","journal-title":"Int. J. Pharm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.3390\/pharmaceutics14122742","article-title":"Lipid and polymeric nanoparticles: successful strategies for nose-to-brain drug delivery in the treatment of depression and anxiety disorders","volume":"14","author":"Alberto","year":"2022","journal-title":"Pharmaceutics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1016\/j.xphs.2019.08.027","article-title":"Analyzing nanotheraputics-based approaches for the management of psychotic disorders","volume":"108","author":"Annu","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.addr.2021.01.019","article-title":"Overcoming barriers by local drug delivery with liposomes","volume":"174","author":"Antimisiaris","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0306-4522(91)90354-q","article-title":"Central projections of trigeminal primary afferents innervating the nasal mucosa: A horseradish peroxidase study in the rat","volume":"41","author":"Anton","year":"1991","journal-title":"Neuroscience"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104917","DOI":"10.1016\/j.chemphyslip.2020.104917","article-title":"Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with Huntington's disease: pharmacokinetic and brain delivery study","volume":"230","author":"Arora","year":"","journal-title":"Chem. Phys. Lipids"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.2174\/1381612826666200331085854","article-title":"Intranasal lipid particulate drug delivery systems: an update on clinical challenges and biodistribution studies of cerebroactive drugs in Alzheimer's disease","volume":"26","author":"Arora","year":"","journal-title":"Curr. Pharm. Des."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.csbj.2019.09.004","article-title":"Recent advancements in non-invasive formulations for protein drug delivery","volume":"17","author":"Bajracharya","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","article-title":"The blood-brain barrier and immune function and dysfunction","volume":"37","author":"Banks","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/pharmaceutics11020084","article-title":"Nanoemulsions for \"Nose-to-Brain\" drug delivery","volume":"11","author":"Bonferoni","year":"2019","journal-title":"Pharmaceutics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","article-title":"Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics","volume":"128","author":"Bourganis","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10143-016-0709-8","article-title":"Current and future strategies for treatment of glioma","volume":"40","author":"Bush","year":"2017","journal-title":"Neurosurg. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jconrel.2018.12.049","article-title":"Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis","volume":"295","author":"Costa","year":"2019","journal-title":"J. Control. Release"},{"key":"B18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"B19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017018693","article-title":"Lipid nanoparticles for nasal\/intranasal drug delivery","volume":"34","author":"Cunha","year":"2017","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"B21","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/cells10051011","article-title":"Nanoparticle delivered anti-miR-141-3p for stroke therapy","volume":"10","author":"Dhuri","year":"2021","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","first-page":"102642","DOI":"10.1016\/j.jddst.2021.102642","article-title":"Recent progress in nanocarriers for direct nose to brain drug delivery","volume":"64","author":"Emad","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"Erdo","year":"2018","journal-title":"Brain Res. Bull."},{"key":"B25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/cmb.2017.0149","article-title":"Prediction of central nervous system side effects through drug permeability to blood-brain barrier and recommendation algorithm","volume":"25","author":"Fan","year":"2018","journal-title":"J. Comput. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.drudis.2018.01.005","article-title":"An update on the role of nanovehicles in nose-to-brain drug delivery","volume":"23","author":"Feng","year":"2018","journal-title":"Drug Discov. Today"},{"key":"B27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1023\/B:NEUR.0000010089.37032.48","article-title":"Ensheathment of the olfactory nerves in the adult rat","volume":"32","author":"Field","year":"2003","journal-title":"J. Neurocytol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","article-title":"Progress and perspectives on targeting nanoparticles for brain drug delivery","volume":"6","author":"Gao","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"B29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1210\/jc.2011-1193","article-title":"Nasal drug delivery systems","volume":"3","author":"Ghori","year":"2015","journal-title":"Overv."},{"key":"B31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The nose revisited: A brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium","volume":"34","author":"Harkema","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.2174\/0929867326666190816231409","article-title":"The design and application of nanomaterials as drug carriers in cancer treatment","volume":"27","author":"Hou","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.3390\/pharmaceutics14102036","article-title":"Risk-assessment-based optimization favours the development of albumin nanoparticles with proper characteristics prior to drug loading","volume":"14","author":"Katona","year":"2022","journal-title":"Pharmaceutics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/pharmaceutics13122049","article-title":"Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier","volume":"13","author":"Lee","year":"","journal-title":"Pharm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3390\/pharmaceutics13122049","article-title":"Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier","volume":"13","author":"Lee","year":"","journal-title":"Pharm."},{"key":"B37","doi-asserted-by":"publisher","first-page":"104795","DOI":"10.1016\/j.phrs.2020.104795","article-title":"Nose to brain drug delivery - a promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion","volume":"159","author":"Long","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3390\/pharmaceutics13111904","article-title":"Selective CNS targeting and distribution with a refined region-specific intranasal delivery technique via the olfactory mucosa","volume":"13","author":"Maigler","year":"2021","journal-title":"Pharmaceutics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2147\/DDDT.S100075","article-title":"Drug delivery in overcoming the blood-brain barrier: role of nasal mucosal grafting","volume":"11","author":"Marianecci","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","journal-title":"Cell Death Differ."},{"key":"B41","doi-asserted-by":"publisher","first-page":"101458","DOI":"10.1016\/j.jddst.2019.101458","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery","volume":"55","author":"Nasirizadeh","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s11064-021-03488-7","article-title":"Lipid-based nanocarriers via nose-to-brain pathway for central nervous system disorders","volume":"47","author":"Nguyen","year":"2022","journal-title":"Neurochem. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"102939","DOI":"10.1016\/j.jddst.2021.102939","article-title":"Intranasal delivery of chitosan decorated nanostructured lipid carriers of buspirone for brain targeting: formulation development, optimization and in-vivo preclinical evaluation","volume":"67","author":"Noorulla","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx J. Am. Soc. Exp. Neurother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/nano11010002","article-title":"Novel therapeutic delivery of nanocurcumin in central nervous system related disorders","volume":"11","author":"Panzarini","year":"2021","journal-title":"Nanomater."},{"key":"B46","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"B47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.colsurfb.2018.07.049","article-title":"Mixed cationic liposomes for brain delivery of drugs by the intranasal route: the acetylcholinesterase reactivator 2-PAM as encapsulated drug model","volume":"171","author":"Pashirova","year":"2018","journal-title":"Colloids Surfaces B-Biointerfaces"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.2174\/1381612826666200424161929","article-title":"Current developments in targeted drug delivery systems for glioma","volume":"26","author":"Patel","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"B49","doi-asserted-by":"publisher","first-page":"102533","DOI":"10.1016\/j.jddst.2021.102533","article-title":"Clozapine loaded nanostructured lipid carriers engineered for brain targeting via nose-to-brain delivery: optimization and in vivo pharmacokinetic studies","volume":"64","author":"Patel","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"509","DOI":"10.37285\/ijpsn.2009.2.2.3","article-title":"Solid lipid nanoparticles: A promising drug delivery technology","volume":"2","author":"Pragati","year":"2009","journal-title":"Int. J. Pharm. Sci. Nanotechnol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1615\/critrevtherdrugcarriersyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"B52","doi-asserted-by":"publisher","first-page":"9283","DOI":"10.2147\/IJN.S277545","article-title":"Cationic solid lipid nanoparticles of resveratrol for hepatocellular carcinoma treatment: systematic optimization, in vitro characterization and preclinical investigation","volume":"15","author":"Rahman","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.2174\/1381612828666220729104433","article-title":"Application of therapeutic nanoplatforms as a potential candidate for the treatment of CNS disorders: challenges and possibilities","volume":"28","author":"Sa","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"B54","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1208\/s12249-021-02072-0","article-title":"Development of imatinib mesylate-loaded liposomes for nose to brain delivery: in vitro and in vivo evaluation","volume":"22","author":"Saka","year":"2021","journal-title":"Aaps Pharmscitech"},{"key":"B55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/cne.10143","article-title":"Trigeminal collaterals in the nasal epithelium and olfactory bulb: A potential route for direct modulation of olfactory information by trigeminal stimuli","volume":"444","author":"Schaefer","year":"2002","journal-title":"J. Comp. Neurology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4155\/tde-2019-0013","article-title":"Nose-to-brain delivery of biologics","volume":"10","author":"Schwarz","year":"2019","journal-title":"Ther. Deliv."},{"key":"B57","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/1872210514666200508121050","article-title":"A patent review on nanotechnology-based nose-to-brain drug delivery","volume":"14","author":"Singh","year":"2020","journal-title":"Recent Pat. Nanotechnol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1248\/cpb.58.650","article-title":"Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine","volume":"58","author":"Singh","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"B59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/pharmaceutics10010034","article-title":"Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting","volume":"10","author":"Sonvico","year":"2018","journal-title":"Pharmaceutics"},{"key":"B60","first-page":"140","article-title":"Intranasal delivery: an approach to bypass the blood brain barrier","volume":"36","author":"Talegaonkar","year":"2004","journal-title":"Indian J. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","article-title":"Levodopa in Parkinson's disease: current status and future developments","volume":"16","author":"Tambasco","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Control. Release"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1007\/s00415-022-11002-4","article-title":"The trigeminal pathways","volume":"269","author":"Terrier","year":"2022","journal-title":"J. Neurology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"B65","volume-title":"Nonolfactory responses from the nasal cavity: Jacobson\u2019s organ and the trigeminal system","author":"Tucker","year":"1971"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.2147\/IJN.S117210","article-title":"Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier","volume":"11","author":"Vieira","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jconrel.2016.11.025","article-title":"Nanotechnology-based drug delivery systems for Alzheimer's disease management: technical, industrial, and clinical challenges","volume":"245","author":"Wen","year":"2017","journal-title":"J. Control. Release"},{"key":"B68","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ijpharm.2018.07.043","article-title":"Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin","volume":"548","author":"Zaman","year":"2018","journal-title":"Int. J. Pharm."},{"key":"B69","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/cns.13560","article-title":"Endothelial glycocalyx as an important factor in composition of blood-brain barrier","volume":"27","author":"Zhao","year":"2021","journal-title":"Cns Neurosci. Ther."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1214450\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T05:29:43Z","timestamp":1692682183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1214450\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":69,"alternative-id":["10.3389\/fcell.2023.1214450"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1214450","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"article-number":"1214450"}}